Prevention of Recurrent Bladder Carcinoma
Bladder carcinoma, particularly non-muscle invasive bladder cancer (NMIBC), exhibits one of the highest recurrence rates among all malignancies. Despite complete tumor resection via transurethral resection of bladder tumor (TURBT), recurrence occurs in approximately 50–70% of cases. Preventing recurrent bladder carcinoma requires a multifaceted approach encompassing risk stratification, adjuvant therapies, vigilant monitoring, and modifiable lifestyle factors.